Skip to content

Evaluation of The Radioprotective Effect of 3D-Printed Intraoral Stents in Children With Brain Cancer.

Evaluation of The Radioprotective Effect of 3D-Printed Intraoral Stents in Children With Brain Cancer: A Randomized Clinical Trial and An In-Vitro Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07715357
Enrollment
72
Registered
2026-07-20
Start date
2026-09-01
Completion date
2028-08-01
Last updated
2026-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medulloblastoma Tumor

Keywords

3D printing, Intraoral stents, Radiation protection, Pediatric Oncology, Radiotherapy

Brief summary

Brain cancer patients undergoing radiotherapy may experience oral complications such as oral mucositis, gingival inflammation, plaque accumulation, radiation-induced caries, and reduced oral-health-related quality of life due to scatter radiation affecting oral tissues. Although intraoral stents are used to protect and reposition oral structures during radiotherapy, conventional stents lack standardization in material properties and thickness, leading to variable radioprotective effectiveness. Advances in 3D printing allow fabrication of customized resin intraoral stents with controlled thickness. However, there is not a lot of research in the literature about the materials that are employed as intraoral radiation stents to reduce the radiation dosage received by healthy tissue. Since these devices can lower radiation exposure to healthy tissues, the current study seeks to evaluate the degree of attenuation of therapeutic radiation with four different thicknesses for the intraoral stents and then assess the clinical effectiveness of the optimized thickness of the 3D-printed resin intraoral stent in reducing oral mucositis, periodontal health status, radiation induced caries, and in improving patient-reported outcomes in brain cancer patients undergoing radiotherapy.

Interventions

DEVICE3D printed intraoral stents.

Custom-designed, biocompatible 3D-printed intraoral stent tailored to the patient's oral anatomy. The device will be manufactured using intraoral scanning data , then will be printed using medical-grade resin. During each radiotherapy session for medulloblastoma, the patient will wear the stent inside the mouth to physically displace and shield healthy oral mucosa away from the high-dose radiation target volume, minimizing radiation-induced mucositis."

Sponsors

Ain Shams University
Lead SponsorOTHER
Children's Cancer Hospital Egypt 57357
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Children will be equally allocated into two groups (36/group) according to the use of the stent as follows: Group I (Control group): Patients with the standard oral care instructions. (Without using intraoral stent) "Using intraoral stent is not established as a standard of care for patients receiving radiotherapy until now, so control group will receive only the accepted standard oral care " Group II (Intervention group): Patients who will wear the 3D printed intraoral stent.

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

1. Patients who will receive 5-7 weeks of definitive radiotherapy for treatment of a diagnosed medulloblastoma tumor. 2. Age less than 18 years old. 3. No Evidence of oral mucositis at baseline (WHO grade 0)

Exclusion criteria

1. Patients with prior exposure to head and neck radiotherapy. 2. Patients who are unable to wear oral stent. 3. Patients with known allergies or hypersensitivity to dental resin materials.

Design outcomes

Primary

MeasureTime frameDescription
Assessment of the oral mucositis severity in children below 18 years old diagnosed with medulloblastoma tumor.Assessments will be carried out weekly during radiotherapy and 3 months after radiotherapy.Will be assessed using WHO "World Health Organization" Oral Mucositis Scale, Scores range from 0 to 4, where 0 = no mucositis and 4 = severe mucositis preventing oral alimentation. Higher scores indicate more severe oral mucositis (worse outcome).

Secondary

MeasureTime frameDescription
Priodontal health status .Assessment will be carried out weekly during radiotherapy and after 3,6 and 12 months.Will be assessed using (Löe \& Silness index),Scores range from 0 to 3, where 0 = no plaque and 3 = abundant plaque accumulation. Higher scores indicate poorer oral hygiene (worse outcome).
Radiation-induced cariesAssessment will be before radiotherapy and 3,6,12 months after radiotherapy.Will be assessed using DMFT index. Scores range from 0 to the maximum number of teeth assessed (e.g., up to 28 permanent teeth excluding third molars, depending on the dentition). Higher scores indicate greater dental caries experience (worse outcome).

Contacts

CONTACTNourhan Mahmoud Shahin, MSc
Nourhanshahin@dent.asu.edu.eg+201065717807
CONTACTClinical Research Center
irb@57357.org+20225351500
PRINCIPAL_INVESTIGATORNourhan Mahmoud Shahin, MSc

Ain Shams University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 22, 2026